Weifeng Tan Selected Research

Weifeng Tan Research Topics

6	Neoplasms (Cancer) 01/2021 - 01/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 06/2014
2	Inflammation (Inflammations) 01/2021 - 09/2011
2	Thrombosis (Thrombus) 01/2018 - 01/2018
2	Hemorrhage 06/2014 - 06/2014
1	Endotoxemia 01/2021
1	Sepsis (Septicemia) 01/2021
1	Cholangiocarcinoma 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2019
1	Liver Diseases (Liver Disease) 08/2019
1	Bile Duct Diseases (Bile Duct Disease) 01/2018
1	Colitis-Associated Neoplasms 01/2016
1	Colitis 01/2016
1	Carcinogenesis 01/2016
1	Bacterial Infections (Bacterial Infection) 06/2014
1	Anemia 06/2014
1	Breast Neoplasms (Breast Cancer) 12/2013
1	Gallbladder Neoplasms (Gallbladder Cancer) 12/2011
1	Liver Neoplasms (Liver Cancer) 01/2011

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2011
2	CytokinesIBA 01/2021 - 09/2011
2	Therapeutic UsesIBA 08/2019 - 12/2011
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 09/2011
1	EnzymesIBA 01/2021
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	schizandrin BIBA 08/2019
1	RNA (Ribonucleic Acid)IBA 08/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	D-Aspartic Acid (D Aspartate)IBA 01/2018
1	CC ChemokinesIBA 01/2018
1	CitrullineIBA 01/2018
1	LigandsIBA 01/2018
1	Dextran SulfateIBA 01/2016
1	AzoxymethaneIBA 01/2016
1	AdipokinesIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 06/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2013
1	human PDCD5 proteinIBA 12/2013
1	SurvivinIBA 12/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2011
1	Small Interfering RNA (siRNA)IBA 01/2011

4	Therapeutics 01/2021 - 01/2011
1	Punctures 01/2021
1	Ligation 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2019
1	Contraindications 01/2018
1	Liver Transplantation 06/2014
1	Pancreaticoduodenectomy 06/2014
1	Drug Therapy (Chemotherapy) 12/2011
1	Radiotherapy 12/2011
1	Injections 01/2011